Semaglutide in Psychiatry—Opportunities and Challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Semaglutide in Psychiatry—Opportunities and Challenges

Published:2024-08-21 Issue: Volume: Page:
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Agarwal Sri Mahavir¹²,Hahn Margaret¹²

Affiliation:

1. Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada

2. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

Abstract

This Viewpoint discusses clinical trial results of glucagon-like peptide 1 receptor agonists for treating the weight gain and cardiovascular disease risk of psychiatric medications.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2822341/jamapsychiatry_agarwal_2024_vp_240014_1723059057.03688.pdf

Reference7 articles.

1. Antipsychotic-induced weight gain in severe mental illness: risk factors and special considerations.;Stogios;Curr Psychiatry Rep,2023

2. Mechanisms of action and therapeutic application of glucagon-like peptide-1.;Drucker;Cell Metab,2018

3. Efficacy and safety of semaglutide 2.4 mg for weight loss in overweight or obese adults without diabetes: an updated systematic review and meta-analysis including the 2-year STEP 5 trial.;Qin;Diabetes Obes Metab,2024

4. Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin—a case series.;Prasad;Ther Adv Psychopharmacol,2023

5. Association of semaglutide with risk of suicidal ideation in a real-world cohort.;Wang;Nat Med,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP